US6225111B1ExpiredUtility

Recombinant equine herpesviruses

46
Assignee: SCHERING PLOUGH VETERINARY CORPriority: Aug 7, 1992Filed: Aug 6, 1993Granted: May 1, 2001
Est. expiryAug 7, 2012(expired)· nominal 20-yr term from priority
A61K 39/00A61K 2039/552C12N 2710/16722C12N 2710/16734A61K 39/245C07K 14/005A61K 2039/5254C12N 2710/16743C12N 7/00C12N 2760/16134A61K 2039/5256A61K 39/12C12N 15/86C12N 2760/16122A61K 39/27A61K 39/092
46
PatentIndex Score
11
Cited by
33
References
7
Claims

Abstract

The present invention relates to a non-naturally occurring, recombinant equine herpesvirus. The invention also relates to a recombinant equine herpesvirus capable of replication which comprises viral DNA from a species of equine herpesvirus and foreign DNA, the foreign DNA being inserted into the equine herpesviral DNA at a site which is not essential for replication of the equine herpesvirus. The invention also relates to DNA encoding the US2 protein of an equine herpesvirus. The invention relates to homology vectors for producing recombinant equine herpesviruses which produce recombinant equine herpesviruses by inserting foreign DNA into equine herpesviral DNA. The invention further relates to a method of producing a fetal-safe, live recombinant equine herpesvirus.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
       1. A recombinant equine herpesvirus which comprises a foreign DNA inserted into an equine herpesvirus genome, wherein the foreign DNA is inserted into a non-essential region, and is expressed in a host cell into which the virus is introduced under the control of a human cytomegalovirus immediate early (HCMV IE) promoter. 
     
     
       2. The recombinant equine herpesvirus of claim  1 , wherein the foreign DNA encodes a polypeptide. 
     
     
       3. The recombinant equine herpesvirus of claim  1 , wherein the foreign DNA encodes  E. coli  β-galactosidase. 
     
     
       4. The recombinant equine herpesvirus of claim  1 , wherein the foreign DNA encodes  E. coli  β-glucoronidase. 
     
     
       5. The recombinant equine herpesvirus of claim  1 , wherein the foreign DNA encodes a detectable marker. 
     
     
       6. The recombinant equine herpesvirus of claim  2 , wherein the polypeptide is equine influenza virus neuraminidase or equine influenza virus hemagglutinin. 
     
     
       7. The recombinant equine herpesvirus of claim  2 , wherein the polypeptide is selected from the group consisting of: equine influenza virus type A/Alaska 91 neuraminidase, equine influenza virus type A/Kentucky 92 neuraminidase, equine influenza virus type A/Prague.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.